Marcelo H. Losso

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 381 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

Jean‐Paul Viard, Jean‐Claude Souberbielle, Ole Kirk et al. · AIDS · 2011 · 192 citations · Full text

Medicine, Infectious Diseases, Nutrition +17

Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study

Daria Podlekareva, Anne Marie W. Efsen, Anna Schultze et al. · The Lancet HIV · 2016 · 68 citations · Full text

Public Health, Infectious Diseases, Epidemiology +15

Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study

Anne Marie W. Efsen, Anna Schultze, Robert F. Miller et al. · Journal of Infection · 2017 · 41 citations · Full text

Public Health, Infectious Diseases, Internal Medicine +15

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Jürgen K. Rockstroh, Lars Peters, Daniel Grint et al. · Journal of Hepatology · 2013 · 40 citations

Life Sciences, Infectious Diseases, Epidemiology +11